United States

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

1 minute read

A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

Sept 17 (Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc (PFE.N)/BioNTech SE COVID-19 vaccine for people aged 16 and older.

Reporting by Manojna Maddipatla in Bengaluru; Editing by Leslie Adler

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters